Document is current
Any future updates will be listed below
-
Authors
Tronieri, Jena S. https://orcid.org/0000-0003-3587-4130
Ghanbari, Eleanor
Chevinsky, Jonathan https://orcid.org/0000-0002-4535-8108
LaFata, Erica M. https://orcid.org/0000-0002-8505-6366
Minnick, Alyssa M. https://orcid.org/0000-0001-7699-0184
Rajpal, Simran https://orcid.org/0000-0001-9756-7510
Wang, Seamus Y. https://orcid.org/0000-0002-7529-6147
Burcaw, Kylie
Berkowitz, Robert I.
Wadden, Thomas A. https://orcid.org/0000-0002-0438-4609
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (K23DK116935)
- License Information
-
More Information
Article History
Received: 25 August 2024
Accepted: 29 January 2025
First Online: 7 March 2025
Competing interests
: J.S.T. reports an investigator-initiated grant, on behalf of the University of Pennsylvania, from Novo Nordisk. T.A.W. reports serving on advisory boards for Novo Nordisk and Weight Watchers, and receiving grants, on behalf of the University of Pennsylvania, from Eli Lilly, Epitomee Medical and Novo Nordisk. R.I.B. served as a consultant to Eisai Pharmaceutical during the conduct of this trial. E.G., J.C., E.M.L., A.M.M., S.R., S.Y.W. and K.B. report no competing interests.
